Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2023-2028)

1.4.2 East Asia Market States and Outlook (2023-2028)

1.4.3 Europe Market States and Outlook (2023-2028)

1.4.4 South Asia Market States and Outlook (2023-2028)

1.4.5 Southeast Asia Market States and Outlook (2023-2028)

1.4.6 Middle East Market States and Outlook (2023-2028)

1.4.7 Africa Market States and Outlook (2023-2028)

1.4.8 Oceania Market States and Outlook (2023-2028)

1.4.9 South America Market States and Outlook (2023-2028)

1.5 Global COVID-19 Drugs Market Size Analysis from 2023 to 2028

1.5.1 Global COVID-19 Drugs Market Size Analysis from 2023 to 2028 by Consumption Volume

1.5.2 Global COVID-19 Drugs Market Size Analysis from 2023 to 2028 by Value

1.5.3 Global COVID-19 Drugs Price Trends Analysis from 2023 to 2028

1.6 COVID-19 Outbreak: COVID-19 Drugs Industry Impact

Chapter 2 Global COVID-19 Drugs Competition by Types, Applications, and Top Regions and Countries

2.1 Global COVID-19 Drugs (Volume and Value) by Type

2.1.1 Global COVID-19 Drugs Consumption and Market Share by Type (2017-2022)

2.1.2 Global COVID-19 Drugs Revenue and Market Share by Type (2017-2022)

2.2 Global COVID-19 Drugs (Volume and Value) by Application

2.2.1 Global COVID-19 Drugs Consumption and Market Share by Application (2017-2022)

2.2.2 Global COVID-19 Drugs Revenue and Market Share by Application (2017-2022)

2.3 Global COVID-19 Drugs (Volume and Value) by Regions

2.3.1 Global COVID-19 Drugs Consumption and Market Share by Regions (2017-2022)

2.3.2 Global COVID-19 Drugs Revenue and Market Share by Regions (2017-2022)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2017-2022 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2017-2022 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global COVID-19 Drugs Sales, Consumption, Export, Import by Regions (2017-2022)

4.1 Global COVID-19 Drugs Consumption by Regions (2017-2022)

4.2 North America COVID-19 Drugs Sales, Consumption, Export, Import (2017-2022)

4.3 East Asia COVID-19 Drugs Sales, Consumption, Export, Import (2017-2022)

4.4 Europe COVID-19 Drugs Sales, Consumption, Export, Import (2017-2022)

4.5 South Asia COVID-19 Drugs Sales, Consumption, Export, Import (2017-2022)

4.6 Southeast Asia COVID-19 Drugs Sales, Consumption, Export, Import (2017-2022)

4.7 Middle East COVID-19 Drugs Sales, Consumption, Export, Import (2017-2022)

4.8 Africa COVID-19 Drugs Sales, Consumption, Export, Import (2017-2022)

4.9 Oceania COVID-19 Drugs Sales, Consumption, Export, Import (2017-2022)

4.10 South America COVID-19 Drugs Sales, Consumption, Export, Import (2017-2022)

Chapter 5 North America COVID-19 Drugs Market Analysis

5.1 North America COVID-19 Drugs Consumption and Value Analysis

5.1.1 North America COVID-19 Drugs Market Under COVID-19

5.2 North America COVID-19 Drugs Consumption Volume by Types

5.3 North America COVID-19 Drugs Consumption Structure by Application

5.4 North America COVID-19 Drugs Consumption by Top Countries

5.4.1 United States COVID-19 Drugs Consumption Volume from 2017 to 2022

5.4.2 Canada COVID-19 Drugs Consumption Volume from 2017 to 2022

5.4.3 Mexico COVID-19 Drugs Consumption Volume from 2017 to 2022

Chapter 6 East Asia COVID-19 Drugs Market Analysis

6.1 East Asia COVID-19 Drugs Consumption and Value Analysis

6.1.1 East Asia COVID-19 Drugs Market Under COVID-19

6.2 East Asia COVID-19 Drugs Consumption Volume by Types

6.3 East Asia COVID-19 Drugs Consumption Structure by Application

6.4 East Asia COVID-19 Drugs Consumption by Top Countries

6.4.1 China COVID-19 Drugs Consumption Volume from 2017 to 2022

6.4.2 Japan COVID-19 Drugs Consumption Volume from 2017 to 2022

6.4.3 South Korea COVID-19 Drugs Consumption Volume from 2017 to 2022

Chapter 7 Europe COVID-19 Drugs Market Analysis

7.1 Europe COVID-19 Drugs Consumption and Value Analysis

7.1.1 Europe COVID-19 Drugs Market Under COVID-19

7.2 Europe COVID-19 Drugs Consumption Volume by Types

7.3 Europe COVID-19 Drugs Consumption Structure by Application

7.4 Europe COVID-19 Drugs Consumption by Top Countries

7.4.1 Germany COVID-19 Drugs Consumption Volume from 2017 to 2022

7.4.2 UK COVID-19 Drugs Consumption Volume from 2017 to 2022

7.4.3 France COVID-19 Drugs Consumption Volume from 2017 to 2022

7.4.4 Italy COVID-19 Drugs Consumption Volume from 2017 to 2022

7.4.5 Russia COVID-19 Drugs Consumption Volume from 2017 to 2022

7.4.6 Spain COVID-19 Drugs Consumption Volume from 2017 to 2022

7.4.7 Netherlands COVID-19 Drugs Consumption Volume from 2017 to 2022

7.4.8 Switzerland COVID-19 Drugs Consumption Volume from 2017 to 2022

7.4.9 Poland COVID-19 Drugs Consumption Volume from 2017 to 2022

Chapter 8 South Asia COVID-19 Drugs Market Analysis

8.1 South Asia COVID-19 Drugs Consumption and Value Analysis

8.1.1 South Asia COVID-19 Drugs Market Under COVID-19

8.2 South Asia COVID-19 Drugs Consumption Volume by Types

8.3 South Asia COVID-19 Drugs Consumption Structure by Application

8.4 South Asia COVID-19 Drugs Consumption by Top Countries

8.4.1 India COVID-19 Drugs Consumption Volume from 2017 to 2022

8.4.2 Pakistan COVID-19 Drugs Consumption Volume from 2017 to 2022

8.4.3 Bangladesh COVID-19 Drugs Consumption Volume from 2017 to 2022

Chapter 9 Southeast Asia COVID-19 Drugs Market Analysis

9.1 Southeast Asia COVID-19 Drugs Consumption and Value Analysis

9.1.1 Southeast Asia COVID-19 Drugs Market Under COVID-19

9.2 Southeast Asia COVID-19 Drugs Consumption Volume by Types

9.3 Southeast Asia COVID-19 Drugs Consumption Structure by Application

9.4 Southeast Asia COVID-19 Drugs Consumption by Top Countries

9.4.1 Indonesia COVID-19 Drugs Consumption Volume from 2017 to 2022

9.4.2 Thailand COVID-19 Drugs Consumption Volume from 2017 to 2022

9.4.3 Singapore COVID-19 Drugs Consumption Volume from 2017 to 2022

9.4.4 Malaysia COVID-19 Drugs Consumption Volume from 2017 to 2022

9.4.5 Philippines COVID-19 Drugs Consumption Volume from 2017 to 2022

9.4.6 Vietnam COVID-19 Drugs Consumption Volume from 2017 to 2022

9.4.7 Myanmar COVID-19 Drugs Consumption Volume from 2017 to 2022

Chapter 10 Middle East COVID-19 Drugs Market Analysis

10.1 Middle East COVID-19 Drugs Consumption and Value Analysis

10.1.1 Middle East COVID-19 Drugs Market Under COVID-19

10.2 Middle East COVID-19 Drugs Consumption Volume by Types

10.3 Middle East COVID-19 Drugs Consumption Structure by Application

10.4 Middle East COVID-19 Drugs Consumption by Top Countries

10.4.1 Turkey COVID-19 Drugs Consumption Volume from 2017 to 2022

10.4.2 Saudi Arabia COVID-19 Drugs Consumption Volume from 2017 to 2022

10.4.3 Iran COVID-19 Drugs Consumption Volume from 2017 to 2022

10.4.4 United Arab Emirates COVID-19 Drugs Consumption Volume from 2017 to 2022

10.4.5 Israel COVID-19 Drugs Consumption Volume from 2017 to 2022

10.4.6 Iraq COVID-19 Drugs Consumption Volume from 2017 to 2022

10.4.7 Qatar COVID-19 Drugs Consumption Volume from 2017 to 2022

10.4.8 Kuwait COVID-19 Drugs Consumption Volume from 2017 to 2022

10.4.9 Oman COVID-19 Drugs Consumption Volume from 2017 to 2022

Chapter 11 Africa COVID-19 Drugs Market Analysis

11.1 Africa COVID-19 Drugs Consumption and Value Analysis

11.1.1 Africa COVID-19 Drugs Market Under COVID-19

11.2 Africa COVID-19 Drugs Consumption Volume by Types

11.3 Africa COVID-19 Drugs Consumption Structure by Application

11.4 Africa COVID-19 Drugs Consumption by Top Countries

11.4.1 Nigeria COVID-19 Drugs Consumption Volume from 2017 to 2022

11.4.2 South Africa COVID-19 Drugs Consumption Volume from 2017 to 2022

11.4.3 Egypt COVID-19 Drugs Consumption Volume from 2017 to 2022

11.4.4 Algeria COVID-19 Drugs Consumption Volume from 2017 to 2022

11.4.5 Morocco COVID-19 Drugs Consumption Volume from 2017 to 2022

Chapter 12 Oceania COVID-19 Drugs Market Analysis

12.1 Oceania COVID-19 Drugs Consumption and Value Analysis

12.2 Oceania COVID-19 Drugs Consumption Volume by Types

12.3 Oceania COVID-19 Drugs Consumption Structure by Application

12.4 Oceania COVID-19 Drugs Consumption by Top Countries

12.4.1 Australia COVID-19 Drugs Consumption Volume from 2017 to 2022

12.4.2 New Zealand COVID-19 Drugs Consumption Volume from 2017 to 2022

Chapter 13 South America COVID-19 Drugs Market Analysis

13.1 South America COVID-19 Drugs Consumption and Value Analysis

13.1.1 South America COVID-19 Drugs Market Under COVID-19

13.2 South America COVID-19 Drugs Consumption Volume by Types

13.3 South America COVID-19 Drugs Consumption Structure by Application

13.4 South America COVID-19 Drugs Consumption Volume by Major Countries

13.4.1 Brazil COVID-19 Drugs Consumption Volume from 2017 to 2022

13.4.2 Argentina COVID-19 Drugs Consumption Volume from 2017 to 2022

13.4.3 Columbia COVID-19 Drugs Consumption Volume from 2017 to 2022

13.4.4 Chile COVID-19 Drugs Consumption Volume from 2017 to 2022

13.4.5 Venezuela COVID-19 Drugs Consumption Volume from 2017 to 2022

13.4.6 Peru COVID-19 Drugs Consumption Volume from 2017 to 2022

13.4.7 Puerto Rico COVID-19 Drugs Consumption Volume from 2017 to 2022

13.4.8 Ecuador COVID-19 Drugs Consumption Volume from 2017 to 2022

Chapter 14 Company Profiles and Key Figures in COVID-19 Drugs Business

14.1 Sanofi

14.1.1 Sanofi Company Profile

14.1.2 Sanofi COVID-19 Drugs Product Specification

14.1.3 Sanofi COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.2 Advanz Pharma

14.2.1 Advanz Pharma Company Profile

14.2.2 Advanz Pharma COVID-19 Drugs Product Specification

14.2.3 Advanz Pharma COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.3 Teva

14.3.1 Teva Company Profile

14.3.2 Teva COVID-19 Drugs Product Specification

14.3.3 Teva COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.4 Novartis

14.4.1 Novartis Company Profile

14.4.2 Novartis COVID-19 Drugs Product Specification

14.4.3 Novartis COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.5 Apotex

14.5.1 Apotex Company Profile

14.5.2 Apotex COVID-19 Drugs Product Specification

14.5.3 Apotex COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.6 Shanghai Zhongxisanwei

14.6.1 Shanghai Zhongxisanwei Company Profile

14.6.2 Shanghai Zhongxisanwei COVID-19 Drugs Product Specification

14.6.3 Shanghai Zhongxisanwei COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.7 Kyung Poong

14.7.1 Kyung Poong Company Profile

14.7.2 Kyung Poong COVID-19 Drugs Product Specification

14.7.3 Kyung Poong COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.8 Mylan

14.8.1 Mylan Company Profile

14.8.2 Mylan COVID-19 Drugs Product Specification

14.8.3 Mylan COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.9 Zydus Cadila

14.9.1 Zydus Cadila Company Profile

14.9.2 Zydus Cadila COVID-19 Drugs Product Specification

14.9.3 Zydus Cadila COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.10 Sun Pharma

14.10.1 Sun Pharma Company Profile

14.10.2 Sun Pharma COVID-19 Drugs Product Specification

14.10.3 Sun Pharma COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.11 Rising Pharmaceutical

14.11.1 Rising Pharmaceutical Company Profile

14.11.2 Rising Pharmaceutical COVID-19 Drugs Product Specification

14.11.3 Rising Pharmaceutical COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.12 Guangzhou Baiyunshan Guanghua Pharmaceutical

14.12.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Profile

14.12.2 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Product Specification

14.12.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.13 Ipca Laboratories

14.13.1 Ipca Laboratories Company Profile

14.13.2 Ipca Laboratories COVID-19 Drugs Product Specification

14.13.3 Ipca Laboratories COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.14 KPC Group

14.14.1 KPC Group Company Profile

14.14.2 KPC Group COVID-19 Drugs Product Specification

14.14.3 KPC Group COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.15 Shanghai Pharma

14.15.1 Shanghai Pharma Company Profile

14.15.2 Shanghai Pharma COVID-19 Drugs Product Specification

14.15.3 Shanghai Pharma COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.16 Bayer

14.16.1 Bayer Company Profile

14.16.2 Bayer COVID-19 Drugs Product Specification

14.16.3 Bayer COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.17 Hanlim Pharmaceutical

14.17.1 Hanlim Pharmaceutical Company Profile

14.17.2 Hanlim Pharmaceutical COVID-19 Drugs Product Specification

14.17.3 Hanlim Pharmaceutical COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.18 CSPC Group

14.18.1 CSPC Group Company Profile

14.18.2 CSPC Group COVID-19 Drugs Product Specification

14.18.3 CSPC Group COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.19 Sichuan Sunny Hope

14.19.1 Sichuan Sunny Hope Company Profile

14.19.2 Sichuan Sunny Hope COVID-19 Drugs Product Specification

14.19.3 Sichuan Sunny Hope COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.20 Bristol Laboratories

14.20.1 Bristol Laboratories Company Profile

14.20.2 Bristol Laboratories COVID-19 Drugs Product Specification

14.20.3 Bristol Laboratories COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.21 Jinghua Pharmaceutical Group

14.21.1 Jinghua Pharmaceutical Group Company Profile

14.21.2 Jinghua Pharmaceutical Group COVID-19 Drugs Product Specification

14.21.3 Jinghua Pharmaceutical Group COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.22 Zhongsheng Pharma

14.22.1 Zhongsheng Pharma Company Profile

14.22.2 Zhongsheng Pharma COVID-19 Drugs Product Specification

14.22.3 Zhongsheng Pharma COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.23 North China Pharmaceutical Group

14.23.1 North China Pharmaceutical Group Company Profile

14.23.2 North China Pharmaceutical Group COVID-19 Drugs Product Specification

14.23.3 North China Pharmaceutical Group COVID-19 Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)

Chapter 15 Global COVID-19 Drugs Market Forecast (2023-2028)

15.1 Global COVID-19 Drugs Consumption Volume, Revenue and Price Forecast (2023-2028)

15.1.1 Global COVID-19 Drugs Consumption Volume and Growth Rate Forecast (2023-2028)

15.1.2 Global COVID-19 Drugs Value and Growth Rate Forecast (2023-2028)

15.2 Global COVID-19 Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)

15.2.1 Global COVID-19 Drugs Consumption Volume and Growth Rate Forecast by Regions (2023-2028)

15.2.2 Global COVID-19 Drugs Value and Growth Rate Forecast by Regions (2023-2028)

15.2.3 North America COVID-19 Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.4 East Asia COVID-19 Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.5 Europe COVID-19 Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.6 South Asia COVID-19 Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.7 Southeast Asia COVID-19 Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.8 Middle East COVID-19 Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.9 Africa COVID-19 Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.10 Oceania COVID-19 Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.11 South America COVID-19 Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.3 Global COVID-19 Drugs Consumption Volume, Revenue and Price Forecast by Type (2023-2028)

15.3.1 Global COVID-19 Drugs Consumption Forecast by Type (2023-2028)

15.3.2 Global COVID-19 Drugs Revenue Forecast by Type (2023-2028)

15.3.3 Global COVID-19 Drugs Price Forecast by Type (2023-2028)

15.4 Global COVID-19 Drugs Consumption Volume Forecast by Application (2023-2028)

15.5 COVID-19 Drugs Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology